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Abstract At least eight genes clustered in 1 Mb of DNA
on human chromosome (Chr) 11p15.5 are subject to
parental imprinting, with monoallelic expression in one or
more tissues. Orthologues of these genes show conserved
linkage and imprinting on distal Chr 7 of mice. The ex-
tended imprinted region has a bipartite structure, with at
least two differentially methylated DNA elements (DMRs)
controlling the imprinting of two sub-domains. We pre-
viously described three biallelically expressed genes
(MRPL23, 2G7 and TNNT3) in 100 kb of DNA immedi-
ately downstream of the imprinted H19 gene, suggesting
that H19 marks one border of the imprinted region. Here
we extend this analysis to two additional downstream
genes, HRAS and MUCDHL (mu-protocadherin). We find
that these genes are biallelically expressed in multiple fe-
tal and adult tissues, both in humans and in mice. The
mouse orthologue of a third gene, DUSP8, located be-
tween H19 and MUCDHL, is also expressed biallelically.
The DMR immediately upstream of H19 frequently
shows a net gain of methylation in Wilms tumors, either
via Chr 11p15.5 loss of heterozygosity (LOH) or loss of
imprinting (LOI), but changes in methylation in CpG-rich
sequences upstream and within the MUCDHL gene are
rare in these tumors and do not correlate with LOH or
LOI. These findings are further evidence for a border of
the imprinted region immediately downstream of H19,
and the data allow the construction of an imprinting map
that includes more than 20 genes, distributed over 3 Mb of
DNA on Chr 11p15.5.
Introduction
Parental imprinting causes monoallelic expression of a small
subset of mammalian genes. This has a number of conse-
quences, including non-Mendelian inheritance of neu-
rodevelopmental disorders, typified by Prader-Willi and
Angelman syndromes, and of the preneoplastic over-
growth disorder, Beckwith-Wiedemann syndrome (Maher
and Reik 2000; Nicholls 2000). A role for abnormal func-
tional imprinting of two genes, H19 and IGF2, is also es-
tablished in several types of pediatric cancers, including
Wilms tumor (WT) (Tycko 2000). Consistent with these
findings from human genetics, data from knockout mice
have suggested a disproportionate involvement of im-
printed genes in regulating growth and behavior (Tycko
and Morison 2002).
A striking feature of imprinted genes is that they are
often found clustered together in the genome. The largest
imprinted regions are those on human chromosome (Chr)
11p15.5, the region associated with BWS and WT, and
Chr 15q11-q13, the region associated with PWS and AS.
Genes in these two regions show conserved linkage with
genes on the distal and mid-portions, respectively, of mouse
Chr 7. The overall imprinted region of human Chr 11p15.5/
mouse distal Chr 7 has a bipartite structure, with two dif-
ferentially methylated DNA elements (DMRs) (Brannan
and Bartolomei 1999) controlling the imprinting of two
‘sub-domains’ (Feinberg 2000; Horike et al. 2000). Here
we examine two genes mapping near this imprinted re-
gion, HRAS and MUCDHL, for allele-specific mRNA ex-
pression, and we assess DNA methylation of MUCDHL.
We combine the data with previous information to gener-
ate an updated imprinting map of this region.
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Materials and methods
Analysis of DNA methylation by Southern blotting
For Southern analysis, genomic DNAs (3 µg) from WTs, non-neo-
plastic kidney parenchyma adjacent to the WTs, and a normal fetal
kidney were digested with RsaI, RsaI plus HpaII, or RsaI plus
CfoI, resolved in 1% agarose gels, and transferred to nylon mem-
branes. The blots were hybridized with appropriate probes for
CpG-rich regions, which were generated by PCR of genomic
DNAs using the primers listed in Table 1, and labeled with 
32P-dCTP by random priming (Random primers DNA labeling sys-
tem, Life Technologies, Gaithersburg, Md.). High stringency hy-
bridizations were done at 42 °C in ExpressHyb solution (Clontech,
Palo Alto, Calif.) and the blots were washed for 15 min at room
temperature in 2×SSC/0.1% SDS and then for 1 h at 65 °C in 0.1×
SSC/0.1% SDS.
Analysis of DNA methylation by bisulfite conversion 
and sequencing
The procedure for bisulfite-mediated conversion was similar to
published protocols (Herman et al. 1996). Briefly, genomic DNA
(5 µg in 60 µl of water) was first denatured by adding 2.5 µl of 
5 N NaOH and incubating at 37 °C for 10 min. Hydroquinone (36 µl
of a 10 mM solution) was added, followed by addition of sodium
bisulfite (622 µl of a 3 M solution) and incubation at 50 °C for 
16 h. The bisulfite-converted DNA was then purified using Centri-
con YM-30 spin columns (Millipore, Bedford, Mass.), with elution
in 50 µl of water. The DNA was desulphonated in 0.3 N NaOH at
room temperature for 5 min, and then precipitated by adding an
equal volume of 10 M ammonium acetate, followed by two vol-
umes of ice-cold ethanol. The pellet was washed in 70% ethanol,
dried briefly and dissolved in 50 µl of water. Each subsequent PCR
reaction utilized 2 µl of the resulting DNA solution. Primers for am-
plifying the MUCDHL intragenic CpG-rich region from the bisul-
fite-converted DNA were: (upstream) ATTTGAGTTTTTTGGT-
TGATTTT; (downstream) AATAACATTTATATTCTCCTCTA.
PCR was done using a touchdown procedure with 11 cycles of de-
naturation at 94 °C for 30 s, annealing at 60 °C for 30 s, and exten-
sion at 72 °C for 30 s; followed by 33 cycles using an annealing
temperature of 50 °C, with a final extension at 72 °C for 10 min.
The PCR products were gel-isolated, ligated into the TA-cloning
vector (Promega) and the resulting clones sequenced.
Reverse transcription-PCR (RT-PCR) and analysis 
of allele-specific mRNA expression
Oligo-dT-priming and MuLV reverse transcriptase (Superscript,
Life Technologies) were used to generate single-stranded cDNAs
from mouse and human tissues. These were amplified by PCR us-
ing gene-specific primers and annealing temperatures listed in
Table 1. Cycling employed an initial denaturation at 94 °C for 
4 min, followed by 32 cycles of denaturation at 94 °C for 1 min, an-
nealing at the indicated temperature for 30 s and extension at 72 °C
for 1 min, with a final extension at 72 °C for 7 min. For each gene
of interest, the relative amounts of mRNA derived from each allele
were measured by either single-strand conformation polymor-
phism (SSCP) (Orita et al. 1989) or RFLP analysis. For SSCP and
RFLP, the gel-isolated PCR products were internally radiolabeled
by six cycles of PCR in the presence of 32P-dCTP. After dilution in
SDS/EDTA (0.1%/10 mM) and denaturation for SSCP, or direct
loading of non-denatured restriction enzyme-digested products for
RFLP (Table 1), these were resolved on 8% (Hras, Nttp1) or 6%
(HRAS, MUCDHL) non-denaturing polyacrylamide gels (300 V
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Table 1 PCR primers, conditions and restriction digestion for analysis of genomic SNPs and allele-specific mRNA expression
Gene Primer name Sequence Experiment Annealing Method: 
temp. Restriction enzymea
(oC)
MUCDHL MUCDHL-FOR1 CGTCCTTGTCCACAAGCAC RT-PCR 58 SSCP: AvaI or DdeI
MUCDHL-FOR2 AGCCCCAAGGCTTTGACAAC Genomic PCR
MUCDHL-REV AGATGTAGGAGTCATCACCAC Genomic, RT-PCR
MUCDHL-CpG-F AGGAGCCAAGCCAGGGCAG Internal CpG-rich  61 NA
MUCDHL-CpG-R GGGTGGACAAGGCTCCGAG region probe
SCT-CpG-F CCGGAACTCCGGCCGCAG CpG-island probe 61 NA
SCT-CpG-R GAGGCCAGGACAGAAGGAGGG
HRAS HRAS-FOR TATAAGCTGGTGGTGGTGGGCG RT-PCR 56 SSCP: no digestion
HRAS-REV CGGTATCCAGGATGTCCAACAGG
H19 H19-FOR AACACCTTAGGCTGGTGGGG Genomic, RT-PCR 56 RFLP: RsaI
H19-REV CTAGTCTGGAAGCTCCGACCGA
Mucdhl MuEX7-FOR TGCTGCTGGCACGGGTAAG Genomic PCR 56 NA
MuEX7-REV CCTGGACCTGGACCTCCTTTC
MuEX8-FOR GTTCTTGTTGCCACTGAGTCCTTC Genomic PCR 56 NA
MuEX8-REV GTTGCCATCGTGTGCGTTG
MuEX7-cDNA-FOR CGGGATACTTGGGAGGAAAATG RT-PCR 56 RFLP: RsaI
MuEX9- cDNA-REV CGTGTGCGTTGATGATGAATGTG
Hras Hras-mu-FOR GACATGTCTACTGGA CATC RT-PCR 62 SSCP: AvaII
Hras-mu-REV GATCAACGTGTGCCTCACA
Nttp1 Nttp1-FOR1 GCTGGACAAGTCCATCGAGT RT-PCR 62 RFLP: SmaI
Nttp1-FOR2 GGCCTCTCGGCCCTGTCGG Genomic PCR
Nttp1-REV GAACTCCATCTGGCAGCTGC Genomic, RT-PCR
aRestriction digestion of the radiolabeled RT-PCR products was used either to score RFLPs or to reduce the size of the SSCP fragments
to improve the resolution of the alleles
overnight for SSCP; 500 V, 2–3 h for RFLP). For some genes, it
was necessary to digest with a restriction enzyme (cutting outside
of the polymorphic site) prior to diluting the radiolabeled samples
for the SSCP analysis, to reduce the size of the relevant fragments
and permit better resolution of the alleles (Table 1). The SSCP and
RFLP results were validated by direct sequencing, either with dye-
labeled terminators (ABI 377 Sequencer) or by dideoxy termina-
tion with 35S-dATP labeling and electrophoresis on 6% denaturing
acrylamide gels. Allelic representation in genomic PCR products
(Table 1) served as a control for these experiments.
Results
The imprinted region on human Chr 11p15.5 is shown
schematically in Fig. 1. Indicated on this map are two DNA
elements (DMRs) that show parent-of-origin-dependent
differential CpG methylation which are essential for es-
tablishing the functional imprints of genes in the two sub-
domains. The H19 5′ DMR controls imprinting of H19,
IGF2 and INS (Ins2 in the mouse), while the KvDMR1 el-
ement controls imprinting of KCNQ1, ASCL2 (Mash2),
SLC22A1L and IPL/TSSC3 (Cleary et al. 2001; Fitz-
patrick et al. 2002; Horike et al. 2000). Previous data have
indicated biallelic expression (lack of imprinting) of sev-
eral genes downstream of H19. This direction is telomeric
on human Chr 11p15.5, but centromeric on distal Chr 7 in
mice. Genes assessed for allele-specific mRNA expres-
sion in multiple tissues include the ribosomal protein gene
MRPL23 (Tsang et al. 1995), the RNA gene 2G7 (Yuan et
al. 1996) and the troponin gene TNNT3 (Yuan et al. 1996).
Data from a single post-natal brain sample suggest that
the dopamine receptor gene DRD4, located 1.5 Mb down-
stream of H19, is also expressed biallelically (Cichon et
al. 1996). The HRAS and MUCDHL genes, which are the
main subject of this report, are situated near DRD4, close
to the Chr 11p15.5 telomere (Goldberg et al. 2002; Paris
and Williams 2000).
DNA sequences that are rich in CpG dinucleotides
(CpG islands or CpG-rich intragenic sequences) some-
times show allele-specific methylation when they are in or
near imprinted genes. A prototype is H19, which is densely
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Fig. 1 Map of the imprinted region on human Chr 11p15.5. Genes
in blue are imprinted and expressed from the paternal allele; genes
in red are imprinted and expressed from the maternal allele. As-
signments are based on combined data from mice and humans. The
genes that are the focus of this study are underlined. CD81 is
weakly imprinted in yolk sac of mice, and has not been shown im-
printed in other tissues. OSBPL5 (Obph1) is indicated in ocher be-
cause it is monoallelically expressed only in placenta (Engemann
et al. 2000; Higashimoto et al. 2002). The Tnfrh1 gene is also in-
dicated in ocher and marked by an asterisk, since it does not ap-
pear to have a human orthologue, but it is weakly imprinted in sev-
eral organs of mice (Clark et al. 2002)
Fig. 2a–d DNA methylation at the MUCDHL and H19 loci. Ge-
nomic DNAs from WTs, the non-neoplastic kidney parenchyma
adjacent to the tumor (Ki) and a control fetal kidney (FKi) were di-
gested with the indicated restriction enzymes and analyzed by
Southern blotting. a Blots hybridized with probe A, spanning the
CpG-island upstream of MUCDHL, which overlaps the small SCT
gene. This CpG-island is essentially unmethylated in all normal
samples, indicated by the absence of protected bands after diges-
tion with the methylation-sensitive restriction enzymes HpaII and
CfoI. Faint lower molecular weight bands may represent minor cell
populations with partial methylation. Most WTs also show an un-
methylated pattern, although two cases (WT39 and WT40) show 
a partial gain of methylation. The WT cases are numbered as in 
our previous study (Yeh et al. 2002). WTs 37, 39 and 40 have 
Chr 11p15.5 LOH, while WT38 retains heterozygosity. b Blots
stripped and rehybridized with probe B, spanning an internal CpG-
rich region of MUCDHL. The pattern of partial methylation seen
in the WT DNA closely matches that of the control fetal kidney.
c Blots stripped and rehybridized with probe C, spanning a portion
of the H19 5′ DMR, which includes several binding sites for the
insulator-binding protein CTCF (Bell and Felsenfeld 2000; Frevel
et al. 1999; Hark et al. 2000). This probe (dark bar) weakly cross-
hybridizes with another repeat of this sequence (light bar). The bi-
phasic pattern of completely protected bands and smaller unpro-
tected fragments (vertical bar), seen in the kidney samples, is char-
acteristic of a DMR associated with an imprinted locus. There is
complete methylation in WT37, which has lost the hypomethyl-
ated maternal allele via Chr 11p15.5 LOH. R RsaI, C CfoI, H
HpaII; restriction maps are shown on the right, with RsaI sites in-
dicated by the tall markings, and CfoI or HpaII sites by the short
markings. d Methylation mapping of the MUCDHL intragenic
CpG-rich region by bisulfite-conversion/DNA sequencing in
WT34 (with 11p15.5 LOH) and normal adult kidney. The region
covered in this analysis is shown by the double bar below the map
of MUCDHL in (B). Each line represents one sequenced clone;
methylated CpG dinucleotides are indicated by the filled circles,
and unmethylated CpG dinucleotides by the open circles. A het-
erogeneous pattern of methylation is present in the normal kidney
(Ki) and in the WT, but there is less overall methylation in the WT.
This matches the Southern blot results for this case (not shown)
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methylated, both in the body of the gene and in its up-
stream sequences, on the silent paternal allele, and not
methylated on the transcriptionally active maternal allele
(Bartolomei et al. 1993; Zhang et al. 1993). A pathologi-
cal gain of DNA methylation, correlating with transcrip-
tional silencing, occurs on the maternal allele of H19
(H19mat) in a substantial subset of WTs (Moulton et al.
1994; Taniguchi et al. 1995). Previous studies have sug-
gested that this de novo methylation, sometimes referred
to as “loss of imprinting” (LOI) is specific to H19 and its
immediate upstream sequences (Dao et al. 1999), but
analysis of additional marker loci is of interest.
The MUCDHL gene is preceded at its 5′ end by a clas-
sical CpG-island, overlapping the small upstream secretin
(SCT) gene, and there are CpG-rich areas within the
MUCDHL transcribed sequences. To determine whether
MUCDHL shows an “imprinted pattern” of allele-specific
DNA methylation, and to ask whether this gene is aber-
rantly methylated in WTs, we digested DNAs from eight
WTs, the associated normal kidney parenchyma of each
case, and one normal fetal kidney, with methylation-sensi-
tive restriction enzymes and carried out Southern analy-
sis, hybridizing the blots sequentially with upstream and
internal MUCDHL probes. As shown for representative
samples in Fig. 2a, the upstream CpG-island situated be-
tween SCT and MUCDHL was not detectably methylated
in any of the normal samples, and remained hypomethyl-
ated in most of the WTs (6/8 cases examined). Two WTs
(WT39, WT40) showed partial methylation of this region,
but this increased methylation was not correlated with
Chr 11p15.5 LOH or LOI. The two cases with partial meth-
ylation both showed Chr 11p15.5 LOH, but three other WTs
with LOH, two with LOI and one with neither LOH nor
LOI did not show a gain of methylation (Fig. 2a, and data
not shown). The downstream CpG-rich sequences within
the MUCDHL gene were partially methylated in both nor-
mal and tumor DNAs, with the pattern seen in the WTs
closely approximating that of the control fetal kidney (ex-
ample in Fig. 2b). The heterogeneous pattern of partial
CpG methylation in this intragenic region was confirmed
at higher resolution by bisulfite-conversion/DNA sequenc-
ing (Fig. 2d).
Overall, these findings for MUCDHL match the canon-
ical patterns of methylation expected for most (non-im-
printed) mammalian genes; i.e., lack of methylation in
CpG islands and heterogeneous methylation in CpG-rich
intragenic regions (Paulsen and Ferguson-Smith 2001). In
contrast, the same Southern blots re-hybridized with a
probe for the (imprinted) H19 5′ DMR revealed the ex-
pected sharply biphasic pattern of methylation in the con-
trol kidneys, contrasting with extensive bi-allelic hyper-
methylation in the WTs with Chr 11p15.5 LOH or LOI
(example in Fig. 2c).
To directly assess allele-specific mRNA expression
from the human MUCDHL gene, we next searched for se-
quence polymorphisms that would allow the two alleles to
be distinguished. Screening the expressed sequence tag
(EST) database, followed by direct sequencing of ge-
nomic PCR products, revealed two single-nucleotide poly-
morphisms (SNPs) in MUCDHL exons: a A→G change at
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Fig. 3a–c Biallelic expression of the
human MUCDHL gene. a RT-PCR/
SSCP analysis of samples from indi-
viduals heterozygous for both SNPs.
The haplotypes corresponding to each
allele are indicated on the right. The
two lanes on the left are from individ-
uals homozygous for each haplotype.
b Confirmation of biallelic expres-
sion in the liver of adult 1 by direct
sequencing of the RT-PCR product
through the 2352A/G SNP. Sequenc-
ing chromatograms from the two ho-
mozygotes are shown for comparison.
c Confirmation of biallelic expres-
sion in the kidney and liver of fetus 1
by direct sequencing through the
2370T/C SNP (Ki kidney, Li liver)
position 2352 and a T→C change at position 2370 (the se-
quence for the MUCDHL mRNA is GenBank accession
no. AF301909). From 20 individuals autopsied at various
developmental stages, we identified six who were het-
erozygous for one or both markers: one mid-gestation fe-
tus, three newborns, one four-year-old child, and one
adult. As illustrated for several cases in Fig. 3a, SSCP
analysis indicated biallelic representation in all RT-PCR
products, although there were minor variations in the in-
tensities of the allele-specific bands. Biallelic expression
was confirmed in each case by direct sequencing of the
PCR products (Fig. 3b, and data not shown).
Crossing divergent mouse strains and analyzing allele-
specific RNA expression in the F1 conceptuses is a stan-
dard test for imprinting. Screening of the mouse Mucdhl
sequences in genomic and cDNA PCR products revealed
a SNP, an A→G change at position 822 of the reference
mRNA sequence (GenBank accession no. AK007988),
that distinguished the Mus musculus domesticus-derived
laboratory strain C57BL/6 from Mus musculus castaneus
(CAST). This SNP created an RsaI RFLP. In multiple fe-
tal and adult tissues from interspecific crosses, there was
equal biallelic expression of Mucdhl (Fig. 4a). Impor-
tantly, the relative intensities of the two alleles did not
vary according to the “direction” of the crosses: identical
results were obtained regardless of whether the mother was
CAST or C57BL/6 (Fig. 4a). That the RFLP analysis was
giving a linear readout of allelic expression was verified
by mixing known amounts of pure CAST and C57Bl/6
templates prior to radiolabeling and RFLP analysis (Fig.
4b). The data were further validated by direct sequencing
of the cDNA PCR products, which confirmed equal bial-
lelic expression, independent of the parent-of-origin of the
alleles (Fig. 4c).
The HRAS gene is situated slightly telomeric to
MUCDHL (Fig. 1). The mouse orthologue, Hras, shows
conserved linkage with the other genes in the imprinted
region of mouse distal Chr 7 (although there is an inver-
sion of the entire block of genes in the mouse, relative to
the human). In unpublished data that we cited in a previ-
ous report (Dao et al. 1999), we tested for possible im-
printing of Hras in interspecific mouse crosses, and found
equal biallelic expression in multiple tissues. These data,
which were obtained by SSCP analysis of RT-PCR prod-
ucts spanning an exonic SNP, are shown here in Fig. 5a.
These data were confirmed by direct sequencing (Fig. 5b).
In that experiment, we examined an additional locus, the
mouse Nttp1 gene, which is the orthologue of human
DUSP8, and which is located between H19 and Hras
(Fig. 1). Using a similar approach of RT-PCR and SSCP
analysis, this gene too was found equally expressed from
the two parental alleles in multiple organs from F1 prog-
eny of interspecific mouse crosses. Tissues and stages ex-
amined were brain, whole fetus, liver, heart, extraembry-
onic membranes, and placenta from reciprocal (BL/6 ×
CAST) and (CAST × BL/6) crosses at 12.5 dpc (Fig. 5c),
and these same organs and tissues, as well as lung and ribs
from 14.5 dpc conceptuses (data not shown).
Failure to find common exonic polymorphisms has
thus far prevented us from analyzing human DUSP8.
However, we identified a frequent exonic polymorphism
in the human HRAS gene (a T→C substitution at position
81 of the HRAS mRNA sequence, GenBank accession no.
NM_005343) and utilized RT-PCR across the region con-
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Fig. 4a–c Biallelic expression
of Mucdhl in fetal and adult or-
gans from (F1) interspecific
mouse crosses. a RFLP analy-
sis of RT-PCR products. Some
samples were analyzed in du-
plicate to show the reliability
of the analysis. Most of the fe-
tal-stage samples were ob-
tained at 14.5 days post-coitum
(dpc); the asterisks indicate
samples obtained at 12.5 dpc.
b Template mixing experiment
showing linearity of the RFLP
assay. c Confirmation of the
RT-PCR/RFLP data by direct
sequencing of the RT-PCR
products. Chromatograms from
the products generated from
parental strains (kidney cDNAs)
and from the indicated organs
of the F1 progeny are indi-
cated. The directions of the
crosses are indicated in the
conventional manner (maternal
× paternal) (C CAST, B BL/6,
Ki kidney, Li liver)
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Fig. 5a–c Biallelic expression
of Hras and Nttp1 in mice.
a SSCP analysis showing bi-
allelic expression of Hras in
fetal tissues from interspecific
mouse crosses. Each allele is
resolved as a doublet. b Con-
firmation of biallelic expres-
sion of Hras in yolk sac and
muscle by direct sequencing.
Asterisks mark the SNP distin-
guishing the two alleles, an
A→G change at position 474
of Hras mRNA, GenBank ac-
cession no. NM_008284, pre-
sent in both CAST and in an-
other divergent strain, Mus
musculus mollosinus (MOLD).
c Analysis of allele-specific
expression of the Nttp1 gene.
RT-PCR generated a product
containing an exonic SmaI
RFLP (a C→T change at posi-
tion 1,613 of the Nttp1 mRNA,
GenBank accession no. X95518).
There is equal representation of
both alleles in yolk sac, brain
and placenta, and in whole 
fetus at 12.5 dpc. Similar data
were obtained at 14.5 dpc (not
shown). The results from ge-
nomic PCR are shown as a
control (C CAST, B BL/6,
Pl placenta, YS yolk sac,
Ki kidney, Fe fetus, Lu lung,
Li liver, Mu limb muscle,
Br brain)
Fig. 6a–c Biallelic expression of
human HRAS. a SSCP analysis
showing equal expression of the
two HRAS alleles in fetuses, new-
borns and an adult. Lanes 1, 2
contain RT-PCR products from
homozygotes. b Confirmation of
the SSCP data by direct sequenc-
ing of RT-PCR products through
the HRAS SNP. Sequences from
two homozygotes and two het-
erozygotes are shown. Sequences
were obtained with the reverse
primer. c Monoallelic expression
of the imprinted gene H19 in the
same tissue samples. Results for
the H19 RsaI RFLP (Zhang and
Tycko 1992) in one of the fetuses
are shown. There is biallelic repre-
sentation in the genomic PCR
product (two bands in the lane
+RsaI), and virtually monoallelic
representation in the RT-PCR
product (single band in lanes
+RsaI). The small fragment pro-
duced by RsaI digestion is at a
much lower position on the gel
and is not shown. The size of the
RT-PCR product is smaller than
the genomic PCR product, due to
RNA splicing (Ki kidney, Lu lung,
Li liver, Ad adrenal, He heart,
Sp spleen, Gen genomic PCR)
taining this SNP, followed by SSCP analysis, to examine
allele-specific expression in multiple organs. As shown in
Fig. 6a, liver, kidney, lung, adrenal and heart from each of
three developmental stages (mid-gestation fetus, newborn
and adult) showed equal biallelic expression of HRAS. These
results were confirmed by direct sequencing (Fig. 6b). As
an additional control, we amplified the same single-stranded
cDNA preparations using PCR primers for the H19 gene,
and found the expected pattern of monoallelic expression,
as indicated by RFLP analysis (Fig. 6c).
Discussion
Based on these results, combined with previous data, at
least seven genes in 1.5 Mb of DNA downstream of H19,
namely HRAS, MUCDHL, DRD4, DUSP8, TNNT3, 2G7,
and MRPL23, are biallelically expressed in one or more
organs of humans and/or mice. Since functional imprint-
ing can be exquisitely tissue-specific (for example, Rou-
geulle et al. 1997), it is not possible to definitively ex-
clude imprinting by examining a finite set of tissues. But
given this caveat, the current data strengthen the conclu-
sion that the imprinted region on Chr 11p15.5 has a defi-
nite border, with a substantial length of sub-telomeric
DNA intervening between the telomere and the H19 gene,
at the beginning of the imprinted region. This is consistent
with the notion that imprinting is dictated not by chromo-
somal position per se, but rather by cis-acting elements
that are intrinsic to the DNA sequences in and around im-
printed genes, which have a limited range of action. Ex-
perimental data supporting this model have come from
studies of transgenic mice carrying large-insert (YAC,
BAC) transgenes spanning imprinted genes. In some in-
stances, including experiments with transgenes spanning
H19, the transgenic constructs have faithfully recapitulated
the imprinting of the corresponding endogenous loci, in-
dependently of chromosomal integration sites (Ainscough
et al. 1997).
While H19 marks one border of the imprinted region,
the other border, which must exist centromeric (in hu-
mans) of the strongly imprinted IPL (TSSC3) gene, is less
well defined. We recently documented weak but consis-
tent imprinting of the Tnfrh1 gene in mice (Clark et al.
2002), suggesting that the influence of the imprinting cen-
ter defined by KvDMR1 extends for a considerable dis-
tance. In contrast to all other genes in this region, Tnfrh1
does not seem to have a human orthologue. The NAP1L4
gene is expressed biallelically in humans (Hu et al. 1996),
and the Cars gene is biallelically expressed in mice (En-
gemann et al. 2000). The Osbph1 gene is expressed bial-
lelically in all mouse tissues except placenta (Engemann
et al. 2000). Monoallelic expression from the maternal al-
lele observed in placenta might reflect either imprinting or
expression from maternal cells, but a recent report of an
allelic bias in placenta at 8.5 days post-coitum (a stage at
which there is minimal maternal contamination) supports
imprinting (Higashimoto et al. 2002). More data will be
needed to define the position of this border of the im-
printed region. A more perplexing problem is raised by
the bipartite structure of the imprinted region. It remains
unclear whether the close apposition of the two imprinted
sub-domains is simply a coincidence or alternatively has
some unifying mechanistic basis.
Lastly, what is the biological significance of lack of
imprinting of MUCDHL and HRAS? HRAS is a well-stud-
ied proto-oncogene, and Ras proteins normally function in
intracellular signaling downstream of plasma membrane
receptors. Since the phenotype of homozygous Hras-/-
knockout mice is unexpectedly mild (viable and fertile
without developmental anomalies), a detailed examina-
tion of the heterozygotes has not been undertaken (Este-
ban et al. 2001). Our data showing lack of imprinting of
Hras predict that, if a phenotype can be found due to dele-
tion of this gene, it will segregate in a Mendelian fashion.
Mu-protocadherin, encoded by the MUCDHL gene, is
a developmentally regulated cell adhesion molecule that
is expressed in various epithelial tissues (Goldberg et al.
2000). This protein, which is composed of multiple cad-
herin ectodomains, as well as multiple mucin repeats in its
longer isoform, is displayed on the apical surface of dif-
ferentiated proximal tubule epithelial cells of the kidney,
where it may have additional functions unrelated to adhe-
sion (Goldberg et al. 2002). In principle, cell adhesion
molecules are candidate tumor suppressors, as exempli-
fied by E-cadherin, which is silenced and/or mutated in
human breast and gastric cancers (Guilford et al. 1998;
Hajra and Fearon 2002). While our current data, indicat-
ing minor and infrequent epigenetic modification of the
MUCDHL gene in WTs, do not suggest a tumor suppres-
sor role for mu-protocadherin, future studies of the ex-
pression and CpG-methylation of this gene in adult kid-
ney neoplasms will be of some interest.
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